ArticleCancers2021
EZH1/2 Inhibitors Favor ILC3 Development from Human HSPC-CD34
Laura Damele et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ArticleCancers2021
Laura Damele et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.